DOCSLIB.ORG

Bindsub 243..272

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bindsub 243..272 SUBJECT INDEX accABCD genes, in flavanone synthesis, 177 Aclacinomycin A, 96 Acceptors, of DesVII–Des VIII, 68 biosynthetic pathway of, 100 Acceptor specificity, in directed molecular structure of, 95 glycosyltransferase evolution, 106 Aclarubicins, 96 Acetaldehyde, in ethanol production, molecular structure of, 95 191–192 Acridone synthase (ACS), in polyketide Acetaphenone, in flavonoid synthesis, 176 synthesis, 169 Acetate kinase (ACK), in malonyl-CoA Actinomycetes, macrolide antibiotics from, 64 formation, 179, 180 Activation, of inosine 50-monophosphate Acetic acid, in combinatorial pathway design, dehydrogenase, 36–39 129 Acute myelogenous leukemia, enediynes Acetoacetyl-CoA (coenzyme A) versus, 89 in ethanol production, 192 Acyclic carotenoids, synthesis of, 165 in MVA pathway, 153, 154 Acyclic xanthophylls, biosynthesis of, 124 Acetoacetyl-CoA ligase, in MVA pathway, Acyl carrier protein (ACP) 154 in combinatorial pathway design, 129 Acetoacetyl-CoA thiolase, in MVA pathway, protein–protein interactions and, 133–134 153 Acyltransferase (AT) domain Acetyl-CoA in combinatorial pathway design, 129, in butanol production, 196 130, 132 in ethanol production, 192 protein–protein interactions and, 133 in MVA pathway, 153, 154 Adenosine monophosphate (AMP), polyketides and, 167 biosynthesis of, 2, 3 Acetyl-CoA carboxylase (ACC) Adriamycin, 95–96, 98 in flavanone synthesis, 177–179, 180 molecular structure of, 95 in malonyl-CoA formation, 179 Aerobacter aerogenes, IMPDH in, 5, 18, 26 Acetyl-CoA synthase (ACS), in malonyl-CoA Aglycones. See also Aglycons formation, 179 anthracyclines and, 98–101 N-Acetyl-glucosamine, in teicoplanin, 83 calicheamicin, 91, 92 Acetyl phosphate, in malonyl-CoA macrolide glycosyltransferases and, 66 formation, 179 of vicenistatin, 93 3-Acetylpyridine adenine dinucleotide Aglycone substrates, accepted by OleD, 74 (APAD), in Tritrichomonas foetus,21 Aglycon exchange reactions AcinetobacterCOPYRIGHTED bayli ADP1, in wax ester CalG1-catalyzed, MATERIAL 92 biosynthesis, 124–125 CalG4-catalyzed, 93 Advances in Enzymology and Related Areas of Molecular Biology, Volume 76 Edited by Eric J.Toone Copyright ° 2009 by John Wiley & Sons, Inc. 243 244 SUBJECT INDEX Aglycon exchanges, erythromycins shikimates and, 173–174 and, 70 Amino acid sequences, in glycosyltransferase Aglycons. See also Aglycones design, 101–103 anthracyclines and, 98–101 Aminocoumarins, 86–88 avermectin and, 76–77 molecular structures of, 87 in natural product glycosylation, 59 Aminomalonyl-ACP extender unit, in oleandomycin and, 74–75 combinatorial pathway design, 129, 130 in vicenistatin reactions, 94–95 Ammonia, in purine nucleotide biosynthesis, 2 Aglycon specificity, methymycin and, Ammonia-limited conditions, biosynthesis 66–69 optimization under, 141–142 Agrobacterium tumefaciens Amorpha-4,11-diene monooxygenase, in in artemisinin production, 158 MVA pathway, 154 in ubiquinone production, 166–167 Amorphadiene Aklavinone biosynthetic pathway, 72 in artemisinin synthesis, 158 AknK glycosyltransferase, 96 in terpene biosynthesis, 138 mechanism of action of, 99 Amorphadiene synthase reactions catalyzed by, 97 in artemisinin synthesis, 158 AknS glycosyltransferase, 96, 98, in MVA pathway, 154 100–101 AmpD1 glycosyltransferase, calicheamicin mechanism of action of, 99 and, 93 aknT gene, 98 AMP-dependent protein kinase (ADPK), 41 AknT glycosyltransferase, 98, 100–101 Angiogenesis, flavonols in, 182 mechanism of action of, 99 D6,7-Anhydroerythromycin C, synthesis of, Alanine 172 cytochrome-P450 enzymes and, 189 Anomeric kinases, in natural product in hydroxylated flavonoid synthesis, 190 glycosylation, 59 protein dynamics and, 34 Anthocyanidin synthase (ANS) Alcohol dehydrogenase (Ec-adhE), in butanol in anthocyanin synthesis, 184–185 production, 196–197 in flavonoid pathway, 178–179 Alcohol dehydrogenase (adh), in ethanol Anthocyanins, 175–176, 183–185 production, 192 medicinal uses of, 183 Aldehydes, in epothilone synthesis, 169 from plant cell cultures, 155 Alkaloids, in combinatorial pathway design, synthesis of, 178–179 128 Anthracyclines, 95–101 a-carotene, in carotenoid biosynthesis, 161, mechanism of action of, 96–101 162 Anthurium andraeanum, in anthocyanin a-helix synthesis, 184 of glycosyltransferases, 61, 62 Antibiotics of IMPDH, 33–34 aminocoumarins as, 86–88 a-zearalenol, 94 aromatic polyketides as, 95–101 Amino acid residues, in polyketide synthesis, enediynes as, 88–93 169 glycopeptides as, 78–86 Amino acids macrolactams as, 93–95 in flavanone synthesis, 177 macrolides as, 64–78 in glycosyltransferase classification, 60 nonribosomal peptides as, 78–86 in purine nucleotide biosynthesis, 2 polyketides as, 167 SUBJECT INDEX 245 Anticancer agents/drugs artemisinin from, 157 anthracyclines as, 96 in terpene biosynthesis, 138 terpenoids as, 152 Artemisinic acid pathway, 154 Antimicrobial agents, terpenoids as, 152 Artemisinin, 134, 154 Antioxidants, ubiquinone, 166–167 enhanced production of, 157–158 Apiferol, in flavonoid pathway, 178–179 microbial synthesis of, 158 Apples from plant cell cultures, 157–158 in anthocyanin synthesis, 184 synthesis of, 157 flavonols from, 182–183 in terpene biosynthesis, 138 appY gene, in carotenoid biosynthesis, 164 yeast synthesis of, 158–159 Aquifex aelicus, peptidoglycan GTs of, 62 Aryltetrasaccharide, in calicheamicin, 89 araBAD promoter, carotenoid biosynthesis Aspartate, vancomycin Gtf’s and, 62 and, 140 Aspartate–alanine substitutions, in IMPDH, Arabidopsis thaliana 24–25 in anthocyanin synthesis, 185 Astaxanthin flavonols from, 182–183 biosynthesis of, 164 resveratrol from, 186 in carotenoid biosynthesis, 162 Arabinose, oleandomycin and, 75 ATP binding, to IMPDH subdomain, 41 araGT gene, 101 Autosomal dominant retinitis pigmentosa AraGT glycosyltransferase, 101 (adRP), 40, 41 Aranciamycin, rhamnosylation of, 101 aveBI gene, 75 ArcA regulon, in ethanol production, 193 AveBI glycosyltransferase, 75–77 Archaea calicheamicin and, 93 IMPDH from, 5, 11 reactions catalyzed by, 76 in KEGG database, 126 Avermectin, 75–77 Arginine molecular structure of, 57, 76 IMPDH ligand binding and, 299 reactions of, 76 protein dynamics and, 34–35 AviGT4 glycosyltransferase, 61 species-selective affinity and, 35 Avilamycin, AviGT4 glycosyltransferase of, Aristolocolchine, optimizing biosynthetic 61 pathway for, 139 Azepinomycin, as IMPDH inhibitor, 16 AroE catalysis, in shikimate synthesis, 174, Azithromycin, 64 175 molecular structure of, 65 aro enzymes, in shikimate synthesis, 174–175 Aromatic amino acids, shikimates and, Baccatin III, in Taxol synthesis, 159 173–174 Bacillus subtilis, MEP pathway in, 153 Aromatic flavonoid derivatives, 173–190 Bacteria. See also Microbial synthesis from cytochrome-P450, 186–190 as biofuel synthesis biocatalysts, 191 flavonoids, 175–185 in butanol production, 196 shikimates, 173–175 carotenoid biosynthesis in, 161–165 stilbenes, 185–186 carotenoids in, 160 Aromatic polyketides, 95–101 enterobactins from, 83–85 Artemisia annua in ethanol production, 191–192 artemisinin from, 157, 158, 159 IMPDH from, 5–8, 11 in terpene biosynthesis, 138 in KEGG database, 126 Artemisinic acid, 154 MEP pathway in, 153–155 246 SUBJECT INDEX Bacteria. (Continued) b-zearalenol, 94 terpene cyclases from, 137, 138 Binding sites, of inosine 50-monophosphate ubiquinone from, 166–167 dehydrogenase, 26–29 unnatural carotenoids from, 165–166 Biocatalysis database, 127–128 vancomycin-resistant, 79 Biocatalyst-based processes, green chemistry Bacteriophage P1, in shikimate synthesis, 175 and, 152 Bacteriophage T5, in astaxanthin synthesis, Biocatalysts, microorganisms as, 191 165 BioCyc database, 127 Bacteriophage T7 Biodegradation database, 127–128 in flavanone synthesis, 177 Biofuels, 191–197 in Taxol synthesis, 160 butanol, 191, 195–197 Baker’s yeast, in carotenoid biosynthesis, 163 ethanol, 191–195 Barrel fold structure microbial synthesis of, 152 in IMPDH ligand binding, 27 utility of, 191 in IMPDH molecules, 9 Bioinformatics Bateman domains green chemistry and, 152 defined, 40 in polyketide synthesis, 168–169 of inosine 50-monophosphate in protein engineering and pathway dehydrogenase, 37, 39–42 design, 123 in various proteins, 41–42 Bioreactors, in flavonoid bioproduction, Benzalacetone, medicinal applications of, 168 175 Benzalacetone synthase (BAS), in polyketide Biosynthesis, 151–217 synthesis, 169 of anthocyanins, 184 Benzaldehyde, in flavonoid synthesis, 176 of aromatic derivatives, 173–190 Benzimidazole NAD analog (BAD), 16 of biofuels, 191–197 Berberine, from plant cell cultures, 155 of carotenoids, 160–167 b-carotene of cell walls, 62 in astaxanthin biosynthesis, 164, 165 of epothilones, 169, 170–171 in carotenoid biosynthesis, 161, 162 of ethanol, 191–195 b-carotene hydroxylase (crtZ) future of, 142–143 in astaxanthin biosynthesis, 164 of guanine, 14 in carotenoid biosynthesis, 162 of isoflavones, 180–181 b-carotene ketolase (crtW) of natural products, 197–198 in astaxanthin biosynthesis, 164 of polyketides, 167–173 in carotenoid biosynthesis, 162 of purine nucleotides, 1–4 b-estradiol, 94 of terpenoids, 152–160 b-methylene-biphosphonate (b-TAD, Biosynthetic enzymes b-CH2-TAD). See also Tiazofurin in natural product glycosylation, 59 adenine dinucleotide (TAD) searching for, 124 in IMPDH activation, 38 Biosynthetic pathways IMPDH crystal structure and, 8, 11, 12 design of, 128–138 in IMPDH ligand binding, 28 diversification of, 128–138 kinetic properties of, 5, 6 optimization of, 128, 137, 138–142 NAD analogs of IMPDH and, 16 Biosynthetic reaction sequences, combina- species-selective affinity
Load more

Recommended publications
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • Open Matthew R Moreau Ph.D. Dissertation Finalfinal.Pdf
    The Pennsylvania State University The Graduate School Department of Veterinary and Biomedical Sciences Pathobiology Program PATHOGENOMICS AND SOURCE DYNAMICS OF SALMONELLA ENTERICA SEROVAR ENTERITIDIS A Dissertation in Pathobiology by Matthew Raymond Moreau 2015 Matthew R. Moreau Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy May 2015 The Dissertation of Matthew R. Moreau was reviewed and approved* by the following: Subhashinie Kariyawasam Associate Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Bhushan M. Jayarao Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Mary J. Kennett Professor, Veterinary and Biomedical Sciences Vijay Kumar Assistant Professor, Department of Nutritional Sciences Anthony Schmitt Associate Professor, Veterinary and Biomedical Sciences Head of the Pathobiology Graduate Program *Signatures are on file in the Graduate School iii ABSTRACT Salmonella enterica serovar Enteritidis (SE) is one of the most frequent common causes of morbidity and mortality in humans due to consumption of contaminated eggs and egg products. The association between egg contamination and foodborne outbreaks of SE suggests egg derived SE might be more adept to cause human illness than SE from other sources. Therefore, there is a need to understand the molecular mechanisms underlying the ability of egg- derived SE to colonize the chicken intestinal and reproductive tracts and cause disease in the human host. To this end, the present study was carried out in three objectives. The first objective was to sequence two egg-derived SE isolates belonging to the PFGE type JEGX01.0004 to identify the genes that might be involved in SE colonization and/or pathogenesis.
    [Show full text]
  • Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases
    International Journal of Molecular Sciences Article Comparative Analysis of High-Throughput Assays of Family-1 Plant Glycosyltransferases Kate McGraphery and Wilfried Schwab * Biotechnology of Natural Products, Technische Universität München, 85354 Freising, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-8161-712-912; Fax: +49-8161-712-950 Received: 27 January 2020; Accepted: 21 March 2020; Published: 23 March 2020 Abstract: The ability of glycosyltransferases (GTs) to reduce volatility, increase solubility, and thus alter the bioavailability of small molecules through glycosylation has attracted immense attention in pharmaceutical, nutraceutical, and cosmeceutical industries. The lack of GTs known and the scarcity of high-throughput (HTP) available methods, hinders the extrapolation of further novel applications. In this study, the applicability of new GT-assays suitable for HTP screening was tested and compared with regard to harmlessness, robustness, cost-effectiveness and reproducibility. The UDP-Glo GT-assay, Phosphate GT Activity assay, pH-sensitive GT-assay, and UDP2-TR-FRET assay were applied and tailored to plant UDP GTs (UGTs). Vitis vinifera (UGT72B27) GT was subjected to glycosylation reaction with various phenolics. Substrate screening and kinetic parameters were evaluated. The pH-sensitive assay and the UDP2-TR-FRET assay were incomparable and unsuitable for HTP plant GT-1 family UGT screening. Furthermore, the UDP-Glo GT-assay and the Phosphate GT Activity assay yielded closely similar and reproducible KM, vmax, and kcat values. Therefore, with the easy experimental set-up and rapid readout, the two assays are suitable for HTP screening and quantitative kinetic analysis of plant UGTs. This research sheds light on new and emerging HTP assays, which will allow for analysis of novel family-1 plant GTs and will uncover further applications.
    [Show full text]
  • Supplementary Information
    Supplementary information (a) (b) Figure S1. Resistant (a) and sensitive (b) gene scores plotted against subsystems involved in cell regulation. The small circles represent the individual hits and the large circles represent the mean of each subsystem. Each individual score signifies the mean of 12 trials – three biological and four technical. The p-value was calculated as a two-tailed t-test and significance was determined using the Benjamini-Hochberg procedure; false discovery rate was selected to be 0.1. Plots constructed using Pathway Tools, Omics Dashboard. Figure S2. Connectivity map displaying the predicted functional associations between the silver-resistant gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S3. Connectivity map displaying the predicted functional associations between the silver-sensitive gene hits; disconnected gene hits not shown. The thicknesses of the lines indicate the degree of confidence prediction for the given interaction, based on fusion, co-occurrence, experimental and co-expression data. Figure produced using STRING (version 10.5) and a medium confidence score (approximate probability) of 0.4. Figure S4. Metabolic overview of the pathways in Escherichia coli. The pathways involved in silver-resistance are coloured according to respective normalized score. Each individual score represents the mean of 12 trials – three biological and four technical. Amino acid – upward pointing triangle, carbohydrate – square, proteins – diamond, purines – vertical ellipse, cofactor – downward pointing triangle, tRNA – tee, and other – circle.
    [Show full text]
  • Exploring the Edible Gum (Galactomannan) Biosynthesis and Its Regulation During Pod Developmental Stages in Clusterbean Using Co
    www.nature.com/scientificreports OPEN Exploring the edible gum (galactomannan) biosynthesis and its regulation during pod developmental stages in clusterbean using comparative transcriptomic approach Sandhya Sharma1, Anshika Tyagi1, Harsha Srivastava1, G. Ramakrishna1, Priya Sharma1, Amitha Mithra Sevanthi1, Amolkumar U. Solanke1, Ramavtar Sharma2, Nagendra Kumar Singh1, Tilak Raj Sharma1,3 & Kishor Gaikwad1* Galactomannan is a polymer of high economic importance and is extracted from the seed endosperm of clusterbean (C. tetragonoloba). In the present study, we worked to reveal the stage-specifc galactomannan biosynthesis and its regulation in clusterbean. Combined electron microscopy and biochemical analysis revealed high protein and gum content in RGC-936, while high oil bodies and low gum content in M-83. A comparative transcriptome study was performed between RGC-936 (high gum) and M-83 (low gum) varieties at three developmental stages viz. 25, 39, and 50 days after fowering (DAF). Total 209,525, 375,595 and 255,401 unigenes were found at 25, 39 and 50 DAF respectively. Diferentially expressed genes (DEGs) analysis indicated a total of 5147 shared unigenes between the two genotypes. Overall expression levels of transcripts at 39DAF were higher than 50DAF and 25DAF. Besides, 691 (RGC-936) and 188 (M-83) candidate unigenes that encode for enzymes involved in the biosynthesis of galactomannan were identifed and analyzed, and 15 key enzyme genes were experimentally validated by quantitative Real-Time PCR. Transcription factor (TF) WRKY was observed to be co-expressed with key genes of galactomannan biosynthesis at 39DAF. We conclude that WRKY might be a potential biotechnological target (subject to functional validation) for developing high gum content varieties.
    [Show full text]
  • The Metabolic Building Blocks of a Minimal Cell Supplementary
    The metabolic building blocks of a minimal cell Mariana Reyes-Prieto, Rosario Gil, Mercè Llabrés, Pere Palmer and Andrés Moya Supplementary material. Table S1. List of enzymes and reactions modified from Gabaldon et. al. (2007). n.i.: non identified. E.C. Name Reaction Gil et. al. 2004 Glass et. al. 2006 number 2.7.1.69 phosphotransferase system glc + pep → g6p + pyr PTS MG041, 069, 429 5.3.1.9 glucose-6-phosphate isomerase g6p ↔ f6p PGI MG111 2.7.1.11 6-phosphofructokinase f6p + atp → fbp + adp PFK MG215 4.1.2.13 fructose-1,6-bisphosphate aldolase fbp ↔ gdp + dhp FBA MG023 5.3.1.1 triose-phosphate isomerase gdp ↔ dhp TPI MG431 glyceraldehyde-3-phosphate gdp + nad + p ↔ bpg + 1.2.1.12 GAP MG301 dehydrogenase nadh 2.7.2.3 phosphoglycerate kinase bpg + adp ↔ 3pg + atp PGK MG300 5.4.2.1 phosphoglycerate mutase 3pg ↔ 2pg GPM MG430 4.2.1.11 enolase 2pg ↔ pep ENO MG407 2.7.1.40 pyruvate kinase pep + adp → pyr + atp PYK MG216 1.1.1.27 lactate dehydrogenase pyr + nadh ↔ lac + nad LDH MG460 1.1.1.94 sn-glycerol-3-phosphate dehydrogenase dhp + nadh → g3p + nad GPS n.i. 2.3.1.15 sn-glycerol-3-phosphate acyltransferase g3p + pal → mag PLSb n.i. 2.3.1.51 1-acyl-sn-glycerol-3-phosphate mag + pal → dag PLSc MG212 acyltransferase 2.7.7.41 phosphatidate cytidyltransferase dag + ctp → cdp-dag + pp CDS MG437 cdp-dag + ser → pser + 2.7.8.8 phosphatidylserine synthase PSS n.i. cmp 4.1.1.65 phosphatidylserine decarboxylase pser → peta PSD n.i.
    [Show full text]
  • Title Diurnal Metabolic Regulation of Isoflavones and Soyasaponins In
    Diurnal metabolic regulation of isoflavones and soyasaponins Title in soybean roots Matsuda, Hinako; Nakayasu, Masaru; Aoki, Yuichi; Yamazaki, Author(s) Shinichi; Nagano, Atsushi J.; Yazaki, Kazufumi; Sugiyama, Akifumi Citation Plant direct (2020), 4(11) Issue Date 2020-11 URL http://hdl.handle.net/2433/259809 © 2020 The Authors. Plant Direct published by American Society of Plant Biologists and the Society for Experimental Biology and John Wiley & Sons Ltd; This is an open access article under the terms of the Creative Commons Attribution‐ Right NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. Type Journal Article Textversion publisher Kyoto University Received: 23 April 2020 | Revised: 23 September 2020 | Accepted: 14 October 2020 DOI: 10.1002/pld3.286 ORIGINAL RESEARCH Diurnal metabolic regulation of isoflavones and soyasaponins in soybean roots Hinako Matsuda1 | Masaru Nakayasu1 | Yuichi Aoki2 | Shinichi Yamazaki2 | Atsushi J. Nagano3 | Kazufumi Yazaki1 | Akifumi Sugiyama1 1Research Institute for Sustainable Humanosphere, Kyoto University, Gokasho, Abstract Uji, Japan Isoflavones and soyasaponins are major specialized metabolites accumulated in soy- 2 Tohoku Medical Megabank Organization, bean roots and secreted into the rhizosphere. Unlike the biosynthetic pathway, the Tohoku University, Sendai, Japan 3Faculty of Agriculture, Ryukoku University, transporters involved in metabolite
    [Show full text]
  • Application of Human Glycosyltransferases in N-Glycan Synthesis and Their Substrate Specificity Studies
    Georgia State University ScholarWorks @ Georgia State University Chemistry Dissertations Department of Chemistry 12-15-2016 Application of Human Glycosyltransferases in N-glycan Synthesis and Their Substrate Specificity Studies Angie Dayan Calderon Molina Georgia State University Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_diss Recommended Citation Calderon Molina, Angie Dayan, "Application of Human Glycosyltransferases in N-glycan Synthesis and Their Substrate Specificity Studies." Dissertation, Georgia State University, 2016. https://scholarworks.gsu.edu/chemistry_diss/128 This Dissertation is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Chemistry Dissertations by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. APPLICATION OF HUMAN GLYCOSYLTRANSFERASES IN N-GLYCAN SYNTHESIS AND THEIR SUBSTRATE SPECIFICITY STUDIES by ANGIE DAYAN CALDERON MOLINA Under the Direction of Peng G. Wang, PhD ABSTRACT Glycoscience is important in many areas such as human health, energy and material science. Glycans have been shown to be involved in the pathophysiology of almost every major disease. Additional glycan structure knowledge is required to help advance personal medicine, and pharmaceutical developments, among others. For glycoscience to advance there is a need for large quantities of well-defined glycans and have quick access to glycosyltransferases for manipulating glycan synthesis. Herein, we will cover our efforts on studying the substrate specificities of human glycosyltransferases such as FUT8 and Gn-T V, and their application on N-glycan synthesis. Complex asymmetric N-glycan isomer structures have been related to many diseases such as breast cancer, among others.
    [Show full text]
  • Advances in Understanding Glycosyltransferases from A
    Available online at www.sciencedirect.com ScienceDirect Advances in understanding glycosyltransferases from a structural perspective Tracey M Gloster Glycosyltransferases (GTs), the enzymes that catalyse commonly activated nucleotide sugars, but can also be glycosidic bond formation, create a diverse range of lipid phosphates and unsubstituted phosphate. saccharides and glycoconjugates in nature. Understanding GTs at the molecular level, through structural and kinetic GTs have been classified by sequence homology into studies, is important for gaining insights into their function. In 96 families in the Carbohydrate Active enZyme data- addition, this understanding can help identify those enzymes base (CAZy) [1 ]. The CAZy database provides a highly which are involved in diseases, or that could be engineered to powerful predictive tool, as the structural fold and synthesize biologically or medically relevant molecules. This mechanism of action are invariant in most of the review describes how structural data, obtained in the last 3–4 families. Therefore, where the structure and mechanism years, have contributed to our understanding of the of a GT member for a given family has been reported, mechanisms of action and specificity of GTs. Particular some assumptions about other members of the family highlights include the structure of a bacterial can be made. Substrate specificity, however, is more oligosaccharyltransferase, which provides insights into difficult to predict, and requires experimental charac- N-linked glycosylation, the structure of the human O-GlcNAc terization of individual GTs. Determining both the transferase, and the structure of a bacterial integral membrane sugar donor and acceptor for a GT of unknown function protein complex that catalyses the synthesis of cellulose, the can be challenging, and is one of the reasons there are most abundant organic molecule in the biosphere.
    [Show full text]
  • Nucleotide Sugars in Chemistry and Biology
    molecules Review Nucleotide Sugars in Chemistry and Biology Satu Mikkola Department of Chemistry, University of Turku, 20014 Turku, Finland; satu.mikkola@utu.fi Academic Editor: David R. W. Hodgson Received: 15 November 2020; Accepted: 4 December 2020; Published: 6 December 2020 Abstract: Nucleotide sugars have essential roles in every living creature. They are the building blocks of the biosynthesis of carbohydrates and their conjugates. They are involved in processes that are targets for drug development, and their analogs are potential inhibitors of these processes. Drug development requires efficient methods for the synthesis of oligosaccharides and nucleotide sugar building blocks as well as of modified structures as potential inhibitors. It requires also understanding the details of biological and chemical processes as well as the reactivity and reactions under different conditions. This article addresses all these issues by giving a broad overview on nucleotide sugars in biological and chemical reactions. As the background for the topic, glycosylation reactions in mammalian and bacterial cells are briefly discussed. In the following sections, structures and biosynthetic routes for nucleotide sugars, as well as the mechanisms of action of nucleotide sugar-utilizing enzymes, are discussed. Chemical topics include the reactivity and chemical synthesis methods. Finally, the enzymatic in vitro synthesis of nucleotide sugars and the utilization of enzyme cascades in the synthesis of nucleotide sugars and oligosaccharides are briefly discussed. Keywords: nucleotide sugar; glycosylation; glycoconjugate; mechanism; reactivity; synthesis; chemoenzymatic synthesis 1. Introduction Nucleotide sugars consist of a monosaccharide and a nucleoside mono- or diphosphate moiety. The term often refers specifically to structures where the nucleotide is attached to the anomeric carbon of the sugar component.
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]
  • 59505, Galactosyltransferase
    59505 (14)Galactosyltransferase Kit Cat.-No. Name Amount 48279 (14) Galactosyltransferase from bovine milk 5 x 1 mg 1 U/mg1) , E.C. 2.4.1.22 40396 100 mg UDP-Galactose UDP-Gal; Uridine 5'-diphospho--D-galactose disodium salt BioChemika, 90% (HPLC) 63536 Manganese(II) chloride tetrahydrate 500 mg puriss. p.a., ACS, 99.0% (KT) 93371 Trizma2) hydrochloride 1 g BioChemika, pH 7.4 61289 -Lactalbumin from bovine milk 25 mg BioChemika, calcium depleted, 90% (HPCE) 79385 Phosphatase alkaline from bovine intestinal mucosa 200 l BioChemika, solution (clear), >10000 U/ml3), E.C. 3.1.3.1 1) 1 U corresponds to the amount of enzyme, which transfers 1 µmol of galactose from UDP-galactose to D-glucose per minute at pH 8.4 and 30°C in the presence of -lactalbumin. 2) Trizma is a registered trademark of Sigma-Aldrich Biotechnology, L.P. 3) 1 U corresponds to the amount of enzyme, which hydrolyzes 1 mol 4-nitrophenyl phosphate per minute at pH 9.8 and 37 °C. Glycosyltransferase Kits As part of our commitment to the progress of biocatalysis in synthetic chemistry, Sigma-Aldrich has, in the past few years, developed and produced new glycosyltransferases for preparative carbohydrate synthesis. Several recombinant glycosyltransferases are now available from well-established fermentation processes and can be offered for synthetic applications. Employing metabolic pathway engineering, researchers at Kyowa Hakko Kogyo Inc. (Tokyo, Japan) recently developed a large-scale production system for many nucleoside mono- and diphosphate sugar donors.41-44 This technological breakthrough can be expected to enable industrial-scale economic synthesis of oligosaccharides and glycoconjugates in the near future.7 In order to support and stimulate scientific research in enzymatic carbohydrate synthesis, Sigma-Aldrich and Kyowa Hakko have agreed to cooperate in the development of various glycosyltransferase kits.
    [Show full text]